We have completed maintenance on DiscoverMagazine.com and action may be required on your account. Learn More

Developing A Drug To Identify And Target Tricky Cancer Cells

Cancer cells are extremely adept at flying under the immune system’s radar. But recent research points to a way of making certain cancers more targetable.

By Connor Lynch
Oct 26, 2022 1:00 PM
Cancer cells
(Credit: Design_Cells/Shutterstock)

Newsletter

Sign up for our email newsletter for the latest science news
 

Cancer is a tricky disease to tackle. The simplicity and universality of the name belies the breadth and diversity of cancers out there. They attack every inch of the body in a myriad of ways, using a variety of tactics and DNA they can edit on the fly to evade capture and bypass our body’s defenses.

One commonality between them, though, is that they all come from within (apart from a few rare, contagious cancers like the Tasmanian devil’s facial tumor disease). They’re built from your cells. And that’s one of the greatest obstacles to treating cancers with broad-spectrum immunotherapies: It’s really difficult for your immune system to distinguish cancer cells from regular cells.


0 free articles left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

0 free articlesSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!

Subscribe

Already a subscriber?

Register or Log In

Stay Curious

Sign up for our weekly newsletter and unlock one more article for free.

 

View our Privacy Policy


Want more?
Keep reading for as low as $1.99!


Log In or Register

Already a subscriber?
Find my Subscription

More From Discover
Recommendations From Our Store
Shop Now
Stay Curious
Join
Our List

Sign up for our weekly science updates.

 
Subscribe
To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2024 Kalmbach Media Co.